Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II - Zhi-Bin Wang; Zhi-Bin Wang; Zhi-Bin Wang; De-Hua Liao; Guang Lei; Zhao-Qian Liu; Zhao-Qian Liu; Nayiyuan Wu; Nayiyuan Wu; Jing Wang; Jing Wang (Frontiers in Pharmacology)